+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Calcifediol Market - Forecasts from 2025 to 2030

  • PDF Icon

    Report

  • 120 Pages
  • December 2024
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 5602591
The Calcifediol Market is expected to grow at a CAGR of 6.24%, reaching a market size of US$2.63 billion in 2030 from US$1.94 billion in 2025.

Calcifediol is a form of Vitamin D, also known as 25-hydroxyvitamin D3, produced by theliver by the process of hydroxylation of Vitamin D3 that we get from sunlight or diet. It is further hydroxylated in the kidney to form Calcitriol, an active form of vitamin D3.

Calcifediol in capsule or liquid dosage treats vitamin D deficiency or insufficiency, refractory rickets, familial hypophosphatemia, and secondary hypoparathyroidism. It is used to treat hypocalcemia and renal osteodystrophy in patients suffering from chronic renal failure. It is used with calcium to prevent osteoporosis. It is also used in animal feed to improve its vitamin D level and feed conversation ratio by improving the overall quality of livestock and poultry.

The rising demand for calcifediol is attributed to its more advantageous features than the other forms of vitamin D. Calcifediol is 3 times more potent than cholecalciferol, commonly used to treat vitamin D deficiency. At the same time, its absorption rate is higher than that of other forms of vitamin D. Furthermore, the increasing Vitamin D deficiency worldwide, along with theaging population, is driving the market growth for calcifediol in the form of supplements. Moreover, its use in treating secondary hyperparathyroidism, managing hypocalcemia, and preventing osteoporosis is leading to market expansion.

Calcifediol Market Drivers

Rising Vitamin D deficiency, along with rising health awareness about micronutrient supplementation, will drive the calcifediol market growth

Globally, there is anincrease in number of people with Vitamin D deficiency. The number of geriatric populations is also rising worldwide. The rising Vitamin D deficiency among the people, including theaged population, is creating demand for Vitamin D supplements. Calcifediol, a better alternative than other vitamin D, provides aneffective solution to meet the demand for vitamin D in calcifediol supplements. Additionally, there is increasing health awareness among youth for their health and wellness. This has led to increased demand for micronutrients, resulting in a significant rise in the need for calcifediol supplements for vitamin D supplementation.

As per a study by theNational Center of Biotechnology Information, 76.6% of participants had serum 25-hydroxyvitamin D deficiency below 75 nmol/l, showing ahigher prevalence of deficiency of vitamin D. Globally, approx. 30-45% of people have vitamin D deficiency, making it around 1 billion.

Calcifediol Market geographical outlook

North America would be the largest market shareholder for calcifediol in the forecast period.

Region-wise, the global market is segmented into Asia-Pacific, North America, South America, Europe, Middle East and Africa. In the forecast period, North America would hold the largest market share for Calcifediol.

There are increasing trends among people in North America, compared toother regions, for dietary supplements. With theprevalence of advanced healthcare infrastructure and significant innovations and advancement in the health sector, this region is poised for growth in theCalcifediol market. Additionally, North America is experiencing a demographic shift towards theolder population. In theUnited States of America, there would be around 77 million people aged above 65 as per U.S. Census Bureau Project. Hence, North America will dominate this market in the forecast period.

Reasons for buying this report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Calcifediol market is analyzed into the following segments:

By Application

  • Pharmaceuticals
  • Animal Feed
  • Others

By Geography

  • North America
  • South America
  • Europe
  • Middle East and Africa
  • Asia-Pacific

Table of Contents

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits for Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Supplier
4.3.2. Bargaining Power of Buyers
4.3.3. The Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. CALCIFEDIOL MARKET BY APPLICATION
5.1. Introduction
5.2. Pharmaceuticals
5.3. Animal Feed
5.4. Others
6. CALCIFEDIOL MARKET BY GEOGRAPHY
6.1. Introduction
6.2. North America
6.2.1. United States
6.2.2. Canada
6.2.3. Mexico
6.3. South America
6.3.1. Brazil
6.3.2. Argentina
6.3.3. Others
6.4. Europe
6.4.1. UK
6.4.2. Germany
6.4.3. France
6.4.4. Italy
6.4.5. Others
6.5. Middle East and Africa
6.5.1. Saudi Arabia
6.5.2. Israel
6.5.3. Others
6.6. Asia Pacific
6.6.1. Japan
6.6.2. China
6.6.3. India
6.6.4. South Korea
6.6.5. Indonesia
6.6.6. Thailand
6.6.7. Others
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Market Share Analysis
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Competitive Dashboard
8. COMPANY PROFILES
8.1. Chemvon Biotechnolgy Co.
8.2. Haoyuan Chemexpress Co. Ltd.
8.3. BOC Science
8.4. Pharmaffiliates
8.5. DSM-Firmenich
8.6. Carbogen AMCIS
8.7. Chemicea
8.8. Midas Pharma
8.9. ApexBio Technolgy
8.10. OPKO Pharmaceuticals LLC
8.11. Nouveau Healthcare
8.12. Tocris Bioscience

Companies Mentioned

  • Chemvon Biotechnolgy Co.
  • Haoyuan Chemexpress Co. Ltd.
  • BOC Science
  • Pharmaffiliates
  • DSM-Firmenich
  • Carbogen AMCIS
  • Chemical
  • Midas Pharma
  • ApexBio Technolgy
  • OPKO Pharmaceuticals LLC
  • Nouveau Healthcare
  • Tocris Bioscience

Methodology

Loading
LOADING...

Table Information